IMMUPHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.145 GBX | -1.61% |
|
-6.54% | +28.67% |
| 04-29 | Immunovia Announces the Appointment of Lisa Fordas as Clinical Laboratory Director | CI |
| 04-02 | Immupharma jumps amid new IP strategy for P140 technology platform | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUPHARMA PLC | Other Biotechnology & Medical Research | -1.61% | -6.54% | +28.67% | -32.97% | -78.76% | 11.55M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IMM Stock
- Charts ImmuPharma plc
- Comparison Chart
